Eesti - eesti - Ravimiamet

bausch health poland sp. z o.o. - mianseriin - õhukese polümeerikattega tablett - 30mg 20tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - antineoplastilised ained - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.

Euroopa Liit - eesti - EMA (European Medicines Agency)

pharmaswiss ceska republika s.r.o - pegaptaniib - märg macula degeneration - oftalmoloogilised vahendid - macugen on näidustatud neovaskulaarse (märg) vanusega seotud makulaarse degeneratsiooni (amd) raviks.

Eesti - eesti - Ravimiamet

dr. gerhard mann chem.-pharm. fabrik gmbh - loteprednool - silmatilgad, suspensioon - 0,5% 2.5ml 1tk; 0,5% 10ml 1tk; 0,5% 5ml 1tk